Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mas-related G-protein coupled receptor member F (MRGPRF), also known as GPR140 or GPR168, is an orphan member of the Class A G protein-coupled receptors (GPCRs) that lacks identified endogenous ligands. It is suggested to bind neuropeptides and may play roles in the modulation and development of nociceptors, implicating a potential function in pain and itch sensation or modulation[3][4][1]. MRGPRF has also been implicated as a tumor suppressor in preclinical melanoma models, where overexpression suppressed cell proliferation and migration via inhibition of the Akt signaling pathway[2]. The receptor is part of the rapidly-evolving MAS-related GPCR family, which displays unique structural diversity and shallow binding pockets, and is generally considered a potential therapeutic target due to its broad biological effects and involvement in neuroimmune communication[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mas-related G-protein coupled receptor member F (MRGPRF).